Skip to content

Contact Lens Wettability

The Impact of Short Term Wearing Time on In Vivo and Ex Vivo Wettability

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00349063
Enrollment
55
Registered
2006-07-06
Start date
2005-07-31
Completion date
Unknown
Last updated
2006-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia

Brief summary

The purpose of this study is to compare the wettability of contact lenses disinfected with three marketed contact lens care solutions.

Interventions

DRUGSoft contact lens multipurpose disinfection regimen

Sponsors

Alcon Research
CollaboratorINDUSTRY
University of Waterloo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum

Inclusion criteria

1. Has had an oculo-visual examination in the last two years. 2. Is at least 18 years old and has full legal capacity to volunteer or is at least 16 years old, has a parent or guardian's permission to participate in the study and has read the Information and Consent Letter for adolescents. 4\. Has read and understood the Information Consent Letter (Appendix II). 5. Is willing and able to follow participant instructions for product usage and meet the protocol-specified schedule of follow-up visits. 6\. Has a refractive error that is correctable with the prescription of the available study lenses. 7\. Has a refractive error that is correctable to at least 20/25 distance visual acuity with contact lenses in each eye. 8\. Has acceptable fit with the study lenses. 9. Has clear corneas, and ocular clinical findings are considered normal.

Exclusion criteria

1. Has any systemic disease that may affect ocular health. 2. Is using any systemic or topical medications that may affect ocular health. 3. Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that may affect the wearing of contact lenses. 4. Has any clinically significant lid or conjunctival abnormalities, meibomian gland dysfunction, neovascularization, corneal scars or corneal opacities. 5. Has limbal injection, bulbar injection or corneal staining that, in the investigator's opinion, is clinically significant. 6. Has pinguecula and/or pterygium that, in the investigator's judgement, makes contact lens wear inadvisable. 7. Has refractive astigmatism of more than 0.75 D. 8. Has corneal distortion resulting from rigid lens wear. 9. Is aphakic. 10. Has undergone corneal refractive surgery. 11. Is participating in any other type of clinical or research study. 12. Is pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
To investigate the impact of wearing time and contact lens care solutions on in
vivo and ex vivo wettability of currently marketed contact lenses

Secondary

MeasureTime frame
To determine if there is a correlation between in vivo wettability, ex vivo
wettability and in-eye comfort. To determine if comfort and wettability vary
between symptomatic and asymptomatic lens wearers.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026